InspireMD Q3 EPS $(0.12) Beats $(0.15) Estimate, Sales $2.242M Beat $1.996M Estimate. Cash and Equivalents $19.246M
Benzinga Newsdesk 1 hour ago
NewsEarningsEarnings Beats
InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 29.41 percent increase over losses of $(0.17) per share from the same
InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 29.41 percent increase over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $2.242 million which beat the analyst consensus estimate of $1.996 million by 12.31 percent. This is a 11.14 percent decrease over sales of $2.523 million the same period last year.